Vol. 5, No. 32

Savannah River Had to Discard Personal Respirators That Flunked Filtration Tests

The Department of Energy’s Savannah River Site in South Carolina had to discard some N95-style masks last month after testing revealed the face wear could not filter enough particulates to be considered a personal respirator capable of protecting users from COVID-19. The independent Defense Nuclear Facilities Safety Board (DNFSB) disclosed the issue in its most […]
  • West Valley Cleanup Site Begins Remobilizing Workers

    After receiving approval from the Energy Department, the West Valley Demonstration Project in New York state is starting Phase 1 of the return to normal operations as concern over COVID-19 subsides. The “safe and deliberate approach to the phased restart of operations” began Monday, a DOE spokesman said by email Wednesday. Decommissioning and demolition has […]

  • NRC Outlines Role in Evaluating On-Site Disposal of Certain Hanford Waste

    The Nuclear Regulatory Commissioning said Wednesday it will conduct a technical review of an Energy Department proposal to dispose of certain vitrified low-activity radioactive waste at the Hanford Site in Washington state. Speaking at an online public meeting, NRC Senior Risk Analyst David Esh said the agency is acting in a consulting role as the Energy […]

  • DNFSB Reviewing NNSA’s Revised Implementation Plan for Pantex Safety

    As part of what it has dubbed a good-faith effort to better cooperate with the federal government’s independent nuclear health-and-safety watchdog, the National Nuclear Security Administration (NNSA) this month delivered an updated plan for implementing safety recommendations for the Pantex Plant in Texas. Whether the changes will convince the Defense Nuclear Facilities Safety Board (DNFSB) […]

  • SHINE Medical Planning Facilities in Asia, Europe

    SHINE Medical Technologies expects in the next five years to locate facilities in Europe and Asia, one staffer said Wednesday. The company is currently more than a year from receiving anticipated federal regulatory approval to open its first production plant, in Janesville, Wis., for the medical isotope molybdenum-99 (Mo-99). “At full capacity, SHINE intends to […]

Get Published in ExchangeMonitor Publications